| Synthesis of 5-hydroxy-2, 3, 4, 5-tetrahydro-[1 H]-2-benzazepin-4-ones: selective antagonists of muscarinic (M 3) receptors B Bradshaw, P Evans, J Fletcher, ATL Lee, PG Mwashimba, D Oehlrich, ... Organic & Biomolecular Chemistry 6 (12), 2138-2157, 2008 | 50 | 2008 |
| Obesity and its associated risk factors among school-aged children in Sharjah, UAE AR Abduelkarem, SI Sharif, FG Bankessli, SA Kamal, NM Kulhasan, ... PLoS One 15 (6), e0234244, 2020 | 35 | 2020 |
| Risk calculation of developing type 2 diabetes in Libyan adults HES AR Abduelkarem, SI Sharif, AM Hammrouni, SS Aldouibi, WM Albraiki Pract Diab Int 26 (4), 148-151i, 2009 | 22 | 2009 |
| Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19 AMH Faheem Hyder Pottoo, Tareq Abu-Izneid, Abdallah Mohammad Ibrahim, Md ... Saudi Pharmaceutical Journal 29 (2021), 173–187, 2021 | 21 | 2021 |
| 1‐[(Benzofuran‐2‐yl) phenylmethyl] Imidazoles as Inhibitors of 17α‐Hydroxylase: 17, 20‐lyase (P450 17): Species and Tissue Differences AM AL‐HAMROUNI, M AHMADI, PJ NICHOLLS, HJ SMITH, P LOMBARDI, ... Pharmacy and Pharmacology Communications 3 (5‐6), 259-263, 1997 | 16 | 1997 |
| The choice of pharmacy profession as a career: UAE Experience A Abduelkarem, A HAMRROUNI Asian Journal of Pharmaceutical and Clinical Research, 220-226, 2016 | 14 | 2016 |
| Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors AM Hamrouni, N Gudka, KJ Broadley Autonomic and Autacoid Pharmacology 26 (3), 275-284, 2006 | 13 | 2006 |
| Anti-inflammatory agents of the carbamoylmethyl ester class: synthesis, characterization, and pharmacological evaluation AA Basem Sadek, Amar Mansour Hamrouni Journal of Inflammation research 6, 35-43, 2013 | 7 | 2013 |
| Impacts of COVID-19 pandemic on geopolitics, health, economics, education and sociocultural events AM Hamrouni, RS Sharif, SI Sharif, MM Hassanein, AR Abduelkarem Risk Management and Healthcare Policy, 935-943, 2022 | 5 | 2022 |
| Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol MAG Sara Al Rawashdah, Amar Hamrouni, Bassem Sadek, Rawad Amer Journal of Molecular Graphics and Modelling 92, 44-54, 2019 | 3 | 2019 |
| Retrospective cohort study on risk factors for developing ischemic stroke A Sadeq, MA Baraka, A Hamrouni, AA Elnour Pharmacy Practice 20 (3), 1-7, 2022 | 1 | 2022 |
| Development of a multivariable model to predict medication non-adherence risk factor for patients with acute coronary syndrome AS Sadeq, AA Elnour, AM Hamrouni, MA Baraka, AZ Al Meslamani, ... Journal of Pharmaceutical Health Services Research 12 (2), 159-165, 2021 | 1 | 2021 |
| Distress symptoms during the COVID-19 lockdown: A study with the general population of the United Arab Emirates AR Abduelkarem, C Samorinha, SI Sharif, AM Hamrouni, MM Hassanein Pharmacy Practice 20 (2), 1-10, 2022 | | 2022 |
| Osteoporosis Related Knowledge and Attitudes: The Scenario in Tripoli, Libya AR Abduelkarem, AM Hamrouni, MM Alhmadi, AM Tawati Journal of Medical Biomedical and Applied Sciences 7 (8), 272-281, 2019 | | 2019 |
| The Hypoglycemic Effect of Libyan Truffle “Terfezia Boudieri” in Experimentally Induced Diabetic Rat AAAAMH Khaled A. Shakshak1, Ali M. Afan2@ Tripolitana Medical Journal 3 (1), 1-4, 2014 | | 2014 |
| Phytochemical, Antioxidant, Antibacterial and Anti-inflammatory Investigation of the Methanolic Extract of Amaranthus Tricolor Seed. AHAA F. Musa, A. Al atery, S. Aburawi Tripolitana Medical Journal 1 (2), 94-99, 2012 | | 2012 |
| Prescribing Pattern of Selected Agents at General Medicine Department, Tripoli Central Hospital, Libya\International Journal of Excellence in Healthcare Management.-2010, Vol … AR Abduelkarem, AM Hamrouni, NS Ghnan Hamdan Bin Mohammed e-University, 2010 | | 2010 |
| Muscarinic Receptor Ligands as Potential Drugs for the Treatment of Alzheimer's Disease and Overactive Bladder AM Hamrouni CARDIFF, 2004 | | 2004 |
| Supplementary data for: Synthesis of 5-hydroxy-2, 3, 4, 5-tetrahydro-[1H]-2-benzazepin-4-ones; selective antagonists of muscarinic (M3) receptors B Bradshaw, P Evans, J Fletcher, ATL Lee, PG Mwashimba, D Oehlrich, ... | | |
